KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Other Operating Expenses (2018 - 2025)

Historic Other Operating Expenses for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to $49.7 million.

  • Twist Bioscience's Other Operating Expenses rose 839.93% to $49.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $145.3 million, marking a year-over-year increase of 21682.69%. This contributed to the annual value of $48.8 million for FY2025, which is N/A changed from last year.
  • Twist Bioscience's Other Operating Expenses amounted to $49.7 million in Q4 2025, which was up 839.93% from $48.8 million recorded in Q2 2025.
  • In the past 5 years, Twist Bioscience's Other Operating Expenses registered a high of $49.7 million during Q4 2025, and its lowest value of -$1.9 million during Q2 2021.
  • Over the past 5 years, Twist Bioscience's median Other Operating Expenses value was $4.1 million (recorded in 2022), while the average stood at $16.3 million.
  • As far as peak fluctuations go, Twist Bioscience's Other Operating Expenses crashed by 9792.38% in 2021, and later soared by 32421.83% in 2022.
  • Twist Bioscience's Other Operating Expenses (Quarter) stood at $2.8 million in 2021, then soared by 46.32% to $4.1 million in 2022, then plummeted by 85.95% to $581000.0 in 2023, then skyrocketed by 7795.52% to $45.9 million in 2024, then grew by 8.4% to $49.7 million in 2025.
  • Its Other Operating Expenses stands at $49.7 million for Q4 2025, versus $48.8 million for Q2 2025 and $46.8 million for Q1 2025.